Abstract
The MAPK p38α senses environmental stressors and orchestrates inflammatory and immunomodulatory reactions. However, the molecular mechanism how p38α controls immunomodulatory responses in myeloid cells remains elusive. We found that in monocytes and macrophages, p38α activated the mechanistic target of rapamycin (mTOR) pathway in vitro and in vivo. p38α signaling in myeloid immune cells promoted IL-10 but inhibited IL-12 expression via mTOR and blocked the differentiation of proinflammatory CD4+ Th1 cells. Cellular stress induced p38α-mediated mTOR activation that was independent of PI3K but dependent on the MAPK-activated protein kinase 2 and on the inhibition of tuberous sclerosis 1 and 2, a negative regulatory complex of mTOR signaling. Remarkably, p38α and PI3K concurrently modulated mTOR to balance IL-12 and IL-10 expression. Our data link p38α to mTOR signaling in myeloid immune cells that is decisive for tuning the immune response in dependence on the environmental milieu.
Footnotes
This work was supported by the Else-Kröner Fresensius Stiftung (to T.W. and M.D.S.), the Austrian Science Foundation Fonds zur Förderung der Wissenschaftlichen Forschung (SFB F28 to C.L. and M.M.), the Austrian Federal Ministry for Science and Research (GEN-AU III Austromouse to C.L. and M.M.), the National Institutes of Health (Grant AI074957 to J.M.P.), and the Deutsche Forschungsgemeinschaft (to M.G.).
Abbreviations used in this article:
- BMDM
- bone marrow–derived macrophage
- DC
- dendritic cell
- MEF
- mouse embryonic fibroblast
- MK
- MAPK-activated protein kinase
- mTOR
- mechanistic target of rapamycin
- mTORC1
- mTOR complex 1
- TSC
- tuberous sclerosis
- WT
- wild-type.
- Received September 25, 2012.
- Accepted December 11, 2012.
- Copyright © 2013 by The American Association of Immunologists, Inc.